Financhill
Sell
41

MNPR Quote, Financials, Valuation and Earnings

Last price:
$71.09
Seasonality move :
25.93%
Day range:
$70.15 - $74.34
52-week range:
$21.00 - $105.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.33x
Volume:
234K
Avg. volume:
185.4K
1-year change:
193.75%
Market cap:
$471.1M
Revenue:
--
EPS (TTM):
-$3.44

Earnings Data

Next earnings date for MNPR
Mar 24
2026
Most recent earnings per share
-$0.48
Missed by $0.08
(Nov 13/2025)
Consensus Estimate
-$0.40
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MNPR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/24/2026 Q4 -- -- -- -$0.47 --
11/13/2025 Q3 -- -- -$0.48 -$0.40 -$0.08
08/12/2025 Q2 -- -- -$0.35 -$0.48 $0.13
05/13/2025 Q1 -- -- -$0.38 -$0.57 $0.19
03/31/2025 Q4 -- -- -$2.23 -$0.42 -$1.81
11/08/2024 Q3 -- -- -$0.37 -$1.17 $0.80
08/09/2024 Q2 -- -- -$0.49 -$0.47 -$0.02
05/09/2024 Q1 -- -- -$0.51 -$0.85 $0.34
03/28/2024 Q4 -- -- -$0.61 -$0.85 $0.24
11/09/2023 Q3 -- -- -$0.69 -- --
08/11/2023 Q2 -- -- -$0.82 -- --
05/11/2023 Q1 -- -- -$0.93 -- --
03/23/2023 Q4 -- -- -$1.12 -- --
11/10/2022 Q3 -- -- -$0.94 -- --
08/11/2022 Q2 -- -- -$1.09 -- --
05/12/2022 Q1 -- -- -$0.97 -- --
03/24/2022 Q4 -- -- -$1.06 -- --
11/12/2021 Q3 -- -- -$0.98 -- --
08/12/2021 Q2 -- -- -$0.83 -- --
05/13/2021 Q1 -- -- -$0.78 -- --
03/25/2021 Q4 -- -- -$0.93 -- --
11/12/2020 Q3 -- -- -$0.74 -- --
08/06/2020 Q2 -- -- -$0.68 -- --
05/07/2020 Q1 -- -- -$0.51 -- --
03/27/2020 Q4 -- -- -$0.57 -- --
09/30/2019 Q3 -- -- -$0.35 -- --
06/30/2019 Q2 -- -- -$0.43 -- --
03/31/2019 Q1 -- -- -$0.65 -- --
12/31/2018 Q4 -- -- -$0.42 -- --
09/30/2018 Q3 -- -- -$0.30 -- --
06/30/2018 Q2 -- -- -$0.39 -- --
03/31/2018 Q1 -- -- -$0.41 -- --
12/31/2017 Q4 -- -- -$0.34 -- --
09/30/2017 Q3 -- -- -$7.03 -- --
06/30/2017 Q2 -- -- -$0.28 -- --
03/31/2017 Q1 -- -- -$0.18 -- --
12/31/2016 Q4 -- -- -$0.15 -- --
09/30/2016 Q3 -- -- -$0.09 -- --

Monopar Therapeutics, Inc. Earnings Questions

  • How Much did Monopar Therapeutics, Inc. Generate in Revenue Last Quarter?

    Monopar Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Monopar Therapeutics, Inc. Beat Earnings Last Quarter?

    Monopar Therapeutics, Inc. announced earnings per share of -$0.48 which represents a miss of analyst forecast a -$0.40 per share.

  • Is Monopar Therapeutics, Inc. Profitable?

    Monopar Therapeutics, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Monopar Therapeutics, Inc. EPS Next Year?

    Monopar Therapeutics, Inc.'s earnings are forecast to decrease from -$4.11 per share to -$1.77 per share next year representing a decrease of -59.24%.

  • When is Monopar Therapeutics, Inc.'s Earnings Date?

    Monopar Therapeutics, Inc.'s next earnings date is March 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock